The PTEN tumor suppressor gene maps to human chromosome 10q23.3, and this region is known to exhibit high rates of loss of heterozygosity in a variety of human malignancies, including kidney, lung, breast, and prostate cancer (14). This evidence concerns the gene PTEN and Familial prostate cancer.